80
Participants
Start Date
April 30, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
December 31, 2013
Steroid-eluting middle meatal spacer (Nasopore (TM) spacer impregnated with 1 cc of 40mg/mL triamcinolone liquid)
All study arms will receive bilateral Nasopore spacers impregnated with 1 cc of Triamcinolone to remain in the nasal cavity for 1 week post-operatively as per usual protocol.
Post-op Oral Steroids
Post-operative oral prednisone 20 mg QD x 5 days , then 10 mg x 5 days, as per usual protocol.
Richmond Road Diagnostic and Treatment Centre, Calgary
University of Calgary
OTHER